{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T20:52:46Z","timestamp":1776977566411,"version":"3.51.4"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute for Health Research University College London Hospitals Biomedical Research Centre"},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["(088208\/Z\/09\/Z)"],"award-info":[{"award-number":["(088208\/Z\/09\/Z)"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000317","name":"Action Medical Research","doi-asserted-by":"publisher","award":["(SP4409 and GN2169)"],"award-info":[{"award-number":["(SP4409 and GN2169)"]}],"id":[{"id":"10.13039\/501100000317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["(M83-F1)"],"award-info":[{"award-number":["(M83-F1)"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"European Union Seventh Framework Programme","doi-asserted-by":"publisher","award":["305823"],"award-info":[{"award-number":["305823"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.bpobgyn.2018.02.007","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T13:48:34Z","timestamp":1519393714000},"page":"66-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Prophylaxis and treatment of foetal growth restriction"],"prefix":"10.1016","volume":"49","author":[{"given":"Aamod","family":"Nawathe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna L.","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0143-4004(80)80012-9","article-title":"Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy","volume":"1","author":"Pijnenborg","year":"1980","journal-title":"Placenta"},{"issue":"9","key":"10.1016\/j.bpobgyn.2018.02.007_bib2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1471-0528.1977.tb12676.x","article-title":"Fetal growth retardation and the arteries of the placental bed","volume":"84","author":"Brosens","year":"1977","journal-title":"Br J Obstet Gynaecol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2018.02.007_bib3","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1471-0528.1981.tb02222.x","article-title":"Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation","volume":"88","author":"Gerretsen","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2018.02.007_bib4","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/HYPERTENSIONAHA.113.01892","article-title":"Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction relationship to clinical outcome","volume":"62","author":"Lyall","year":"2013","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.bpobgyn.2018.02.007_bib5","doi-asserted-by":"crossref","first-page":"287.e1","DOI":"10.1016\/j.ajog.2016.12.029","article-title":"Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta","volume":"216","author":"Laberrere","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2018.02.007_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1471-0528.2003.t01-1-02163.x","article-title":"Longitudinal quantification of uterine artery blood volume flow changes during gestation in pregnancies complicated by intrauterine growth restriction","volume":"110","author":"Konje","year":"2003","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2018.02.007_bib7","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.ajog.2006.03.065","article-title":"Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction","volume":"195","author":"Savvidou","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1210\/jc.2007-1042","article-title":"Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction","volume":"93","author":"Nevo","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.bpobgyn.2018.02.007_bib9","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1017\/S000711451100691X","article-title":"The Mediterranean diet and fetal size parameters: the generation R Study","volume":"108","author":"Timmermans","year":"2012","journal-title":"Br J Nutr"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1359\/jbmr.090701","article-title":"Low maternal vitamin D status and fetal bone development: cohort study","volume":"25","author":"Mahon","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"issue":"4","key":"10.1016\/j.bpobgyn.2018.02.007_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.ejcn.1602745","article-title":"Major dietary patterns in pregnancy and fetal growth","volume":"62","author":"Knudsen","year":"2008","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"10.1016\/j.bpobgyn.2018.02.007_bib12","first-page":"CD000032","article-title":"Antenatal dietary education and supplementation to increase energy and protein intake","author":"Ota","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.bpobgyn.2018.02.007_bib13","first-page":"CD004905","article-title":"Multiple-micronutrient supplementation for women during pregnancy","author":"Haider","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.bpobgyn.2018.02.007_bib14","first-page":"CD009997","article-title":"Intermittent oral iron supplementation during pregnancy","author":"Pena-Rosas","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.bpobgyn.2018.02.007_bib15","first-page":"CD004736","article-title":"Daily oral iron supplementation during pregnancy","author":"Pena-Rosas","year":"2015","journal-title":"Cochrane database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib16","series-title":"WHO | Calcium supplementation in pregnant women. WHO | Calcium supplementation in pregnant women","author":"Organisation","year":"2013"},{"issue":"6","key":"10.1016\/j.bpobgyn.2018.02.007_bib17","first-page":"CD001059","article-title":"Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems","author":"Hofmeyr","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib18","first-page":"CD004227","article-title":"Antioxidants for preventing pre-eclampsia","author":"Rumbold","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ije\/dyq195","article-title":"Knowledge Synthesis Group. Maternal underweight and the risk of preterm birth and low birth weight: a systematic review and meta-analyses","volume":"40","author":"Han","year":"2011","journal-title":"Int J Epidemiol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2018.02.007_bib20","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/ajcn\/87.6.1750","article-title":"Combined associations of prepregnancy body mass index and gestational weight gain with the outcome of pregnancy","volume":"87","author":"Nohr","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib21","series-title":"Weight gain during pregnancy: reexamining the guidelines","author":"Rasmussen","year":"2009"},{"issue":"3","key":"10.1016\/j.bpobgyn.2018.02.007_bib22","first-page":"292","article-title":"The implications and consequences of maternal obesity on fetal intrauterine growth restriction","volume":"6","author":"Radulescu","year":"2013","journal-title":"J\u00a0Med Life"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00404-006-0219-y","article-title":"Effect of prepregnancy body mass index categories on obstetrical and neonatal outcomes","volume":"275","author":"Abenhaim","year":"2007","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2018.02.007_bib24","first-page":"a2332","article-title":"Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study","volume":"337","author":"Risk","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.bpobgyn.2018.02.007_bib25","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2337\/dc12-1280","article-title":"Paternal metabolic and cardiovascular risk factors for fetal growth restriction: a case-control study","volume":"36","author":"Hillman","year":"2013","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.bpobgyn.2018.02.007_bib26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5694\/j.1326-5377.2008.tb02141.x","article-title":"Effect of smoking among Indigenous and non-Indigenous mothers on preterm birth and full-term low birthweight","volume":"189","author":"Wills","year":"2008","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.bpobgyn.2018.02.007_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jech-2013-202991","article-title":"Smoking cessation in the first trimester reduces most obstetric risks, but not the risks of major congenital anomalies and admission to neonatal care: a population-based cohort study of 1164953 singleton pregnancies in Finland","volume":"68","author":"Raisanen","year":"2014","journal-title":"J\u00a0Epidemiol Community Health"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib28","first-page":"60","article-title":"Effect of maternal smoking cessation before and during early pregnancy on fetal and childhood growth","volume":"24","author":"Suzuki","year":"2014","journal-title":"J\u00a0Epidemiol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2018.02.007_bib29","first-page":"CD001055","article-title":"Interventions for promoting smoking cessation during pregnancy","author":"Lumley","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib30","first-page":"e0170946","article-title":"A\u00a0systematic review of maternal smoking during pregnancy and fetal measurements with meta-analysis","author":"Abraham","year":"2017"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1471-0528.2002.01020.x","article-title":"Maternal use of cannabis and pregnancy outcome","volume":"109","author":"Fergusson","year":"2002","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2018.02.007_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.11.013","article-title":"Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses","volume":"204","author":"Gouin","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2018.02.007_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.04.016","article-title":"Knowledge Synthesis Group on Determinants of Preterm\/LBW Births. Prenatal amphetamine exposure and birth outcomes: a systematic review and metaanalysis","volume":"205","author":"Ladhani","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2018.02.007_bib34","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/aje\/kwg201","article-title":"Patterns of alcohol use before and during pregnancy and the risk of small-for-gestational-age birth","volume":"158","author":"Whitehead","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.bpobgyn.2018.02.007_bib35","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1471-0528.2011.03050.x","article-title":"Dose-response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)-a systematic review and meta-analyses","volume":"118","author":"Patra","year":"2011","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib36","series-title":"Cochrane database of systematic reviews. Chichester, UK","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","author":"Abalos","year":"2014"},{"issue":"5","key":"10.1016\/j.bpobgyn.2018.02.007_bib37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.bpobgyn.2018.02.007_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10096-014-2224-6","article-title":"Risk of intrauterine growth restriction among HIV-infected pregnant women: a cohort study","volume":"34","author":"L\u00f3pez","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"35","key":"10.1016\/j.bpobgyn.2018.02.007_bib39","doi-asserted-by":"crossref","first-page":"e4777","DOI":"10.1097\/MD.0000000000004777","article-title":"Maternal HCV infection is associated with intrauterine fetal growth disturbance","volume":"95","author":"Huang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib40","first-page":"CD000169","article-title":"Drugs for preventing malaria in pregnant women","volume":"4","author":"Garner","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1471-0528.2010.02880.x","article-title":"Malaria in pregnancy: the difficulties in measuring birthweight. Vol. 118","author":"Rijken","year":"2011","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2018.02.007_bib42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM198908103210603","article-title":"The use of aspirin to prevent ppregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostcyclin in relatively high risk pregnancies","volume":"321","author":"Schiff","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"8842","key":"10.1016\/j.bpobgyn.2018.02.007_bib43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0140-6736(93)92988-6","article-title":"Anonymous. Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Italian study of aspirin in pregnancy","volume":"341","year":"1993","journal-title":"Lancet"},{"issue":"8898","key":"10.1016\/j.bpobgyn.2018.02.007_bib44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group","volume":"343","year":"1994","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib45","series-title":"Hypertension in pregnancy [Internet]. Hypertension in pregnancy (QS35)","author":"NICE guidance","year":"2013"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib46","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2018.02.007_bib48","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2018.02.007_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.placenta.2014.12.008","article-title":"Low molecular weight heparin therapy during pregnancy is associated with elevated circulatory levels of placental growth factor","volume":"36","author":"Yinon","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib50","first-page":"1","article-title":"Low molecular weight heparin improves endothelial function in pregnant women at high risk of preeclampsia","author":"Mclaughlin","year":"2016","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1538-7836.2008.03230.x","article-title":"Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial","volume":"7","author":"Rey","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9955","key":"10.1016\/j.bpobgyn.2018.02.007_bib52","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(14)60793-5","article-title":"Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial","volume":"384","author":"Rodger","year":"2014","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.bpobgyn.2018.02.007_bib53","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood-2011-11-391383","article-title":"Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial","volume":"119","author":"Martinelli","year":"2012","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.bpobgyn.2018.02.007_bib54","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"0","key":"10.1016\/j.bpobgyn.2018.02.007_bib55","first-page":"1","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"0","author":"Rodger","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bpobgyn.2018.02.007_bib56","doi-asserted-by":"crossref","first-page":"296.e1","DOI":"10.1016\/j.ajog.2017.01.014","article-title":"Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial","volume":"216","author":"Groom","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2018.02.007_bib57","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/AOG.0000000000001673","article-title":"Enoxaparin and aspirin compared with aspirin alone to prevent placenta-mediated pregnancy complications","volume":"128","author":"Haddad","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib58","first-page":"CD000137","article-title":"Maternal oxygen administration for suspected impaired fetal growth","author":"Say","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib59","series-title":"Developing new pharmaceutical treatments for obstetric conditions","author":"David","year":"2015"},{"issue":"2","key":"10.1016\/j.bpobgyn.2018.02.007_bib60","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0002-9378(96)70432-5","article-title":"Nitric oxide is involved in flow-induced dilation of isolated human small fetoplacental arteries","volume":"174","author":"Learmont","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2018.02.007_bib61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0029-7844(94)00417-C","article-title":"Maternal volume homeostasis in early pregnancy in relation to fetal growth restriction","volume":"85","author":"Duvekot","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2018.02.007_bib62","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3109\/00016349509021176","article-title":"Severely impaired fetal growth is preceded by maternal hemodynamic maladaptation in very early pregnancy","volume":"74","author":"Duvekot","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.placenta.2012.09.015","article-title":"Endothelial eNOS\/arginase imbalance contributes to vascular dysfunction in IUGR umbilical and placental vessels","volume":"34","author":"Krause","year":"2013","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib64","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/HYPERTENSIONAHA.112.201996","article-title":"Endothelial NO synthase augments fetoplacental blood flow, placental vascularization, and fetal growth in mice","volume":"61","author":"Kulandavelu","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib65","article-title":"Nitric oxide (NO) donors and haemodynamic changes in fetal growth restriction","author":"Tiralongo","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib66","doi-asserted-by":"crossref","DOI":"10.1113\/JP273331","article-title":"Dietary interventions for fetal growth restriction \u2013 therapeutic potential of dietary nitrate supplementation in pregnancy","author":"Cottrell","year":"2017","journal-title":"J\u00a0Physiol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2018.02.007_bib67","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.ajog.2003.12.024","article-title":"Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries","volume":"190","author":"Wareing","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2018.02.007_bib68","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1210\/jc.2004-1831","article-title":"Sildenafil citrate (viagra) enhances vasodilatation in fetal growth restriction","volume":"90","author":"Wareing","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.bpobgyn.2018.02.007_bib69","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/10641950802601278","article-title":"A\u00a0randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia","volume":"28","author":"Samangaya","year":"2009","journal-title":"Hypertens Pregnancy"},{"issue":"3","key":"10.1016\/j.bpobgyn.2018.02.007_bib70","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/HYPERTENSIONAHA.116.07662","article-title":"Maternal administration of sildenafil citrate alters fetal and placental growth and fetal-placental vascular resistance in the growth-restricted ovine fetus","volume":"68","author":"Oyston","year":"2016","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib71","doi-asserted-by":"crossref","first-page":"102.e1","DOI":"10.1016\/j.ajog.2008.08.029","article-title":"The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus","volume":"200","author":"Miller","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2018.02.007_bib72","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1471-0528.2010.02879.x","article-title":"Sildenafil citrate therapy for severe early-onset intrauterine growth restriction","volume":"118","author":"Von Dadelszen","year":"2011","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib73","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2046-4053-3-23","article-title":"STRIDER: sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction\u202f? a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis","volume":"3","author":"Ganzevoort","year":"2014","journal-title":"Syst Rev"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib74","article-title":"Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial","author":"Sharp","year":"2017","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib75","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-017-1594-z","article-title":"STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials","volume":"17","author":"Pels","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"issue":"9","key":"10.1016\/j.bpobgyn.2018.02.007_bib76","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/ars.2009.2945","article-title":"The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia","volume":"12","author":"Wang","year":"2010","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"10.1016\/j.bpobgyn.2018.02.007_bib77","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.ajpath.2013.01.001","article-title":"Reduced cystathionine \u03b3-lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator","volume":"182","author":"Cindrova-Davies","year":"2013","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2018.02.007_bib78","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1681\/ASN.2013030291","article-title":"Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor","volume":"25","author":"Holwerda","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2018.02.007_bib79","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.atherosclerosis.2004.07.023","article-title":"LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study","volume":"177","author":"Belo","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib80","first-page":"26","article-title":"Pravastatin attenuates hypertension and angiogenic imbalance in placental ischemia induced hypertension in the rat","author":"Bauer","year":"2012","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.bpobgyn.2018.02.007_bib81","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/bdrb.20085","article-title":"Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study","volume":"77","author":"Ofori","year":"2006","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"Pt 2","key":"10.1016\/j.bpobgyn.2018.02.007_bib82","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1113\/jphysiol.2011.217968","article-title":"Statin treatment depresses the fetal defence to acute hypoxia via increasing nitric oxide bioavailability","volume":"590","author":"Kane","year":"2012","journal-title":"J\u00a0Physiol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2018.02.007_bib83","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/AOG.0b013e31827d8ad5","article-title":"Pravastatin for the prevention of preeclampsia in high-risk pregnant women","volume":"121","author":"Costantine","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2018.02.007_bib84","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1172\/JCI86957","article-title":"Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy","volume":"126","author":"Lefkou","year":"2016","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.bpobgyn.2018.02.007_bib85","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008211","article-title":"Double blind, randomised, placebo-controlled trial to evaluate the efficacy of esomeprazole to treat early onset pre-eclampsia (PIE Trial): a study protocol","volume":"5","author":"Cluver","year":"2015","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib86","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1034\/j.1600-079X.2001.300104.x","article-title":"Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy","volume":"30","author":"Nakamura","year":"2001","journal-title":"J\u00a0Pineal Res"},{"issue":"4","key":"10.1016\/j.bpobgyn.2018.02.007_bib87","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-079X.2009.00671.x","article-title":"Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy","volume":"46","author":"Richter","year":"2009","journal-title":"J\u00a0Pineal Res"},{"issue":"4","key":"10.1016\/j.bpobgyn.2018.02.007_bib88","doi-asserted-by":"crossref","first-page":"R454","DOI":"10.1152\/ajpregu.00407.2011","article-title":"Melatonin supplementation alters uteroplacental hemodynamics and fetal development in an ovine model of intrauterine growth restriction","volume":"302","author":"Lemley","year":"2012","journal-title":"AJP Regul Integr Comp Physiol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2018.02.007_bib89","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/jpi.12121","article-title":"Antenatal antioxidant treatment with melatonin to decrease newborn neurodevelopmental deficits and brain injury caused by fetal growth restriction","volume":"56","author":"Miller","year":"2014","journal-title":"J\u00a0Pineal Res"},{"issue":"2","key":"10.1016\/j.bpobgyn.2018.02.007_bib90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.transci.2006.05.010","article-title":"Heparin-mediated extracorporeal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsia","volume":"35","author":"Wang","year":"2006","journal-title":"Transfus Apher Sci"},{"issue":"8","key":"10.1016\/j.bpobgyn.2018.02.007_bib91","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1089\/hum.2015.095","article-title":"Recent advancements in cardiovascular gene therapy and vascular biology","volume":"26","author":"Laakkonen","year":"2015","journal-title":"Hum Gene Ther"},{"issue":"19","key":"10.1016\/j.bpobgyn.2018.02.007_bib92","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/gt.2008.102","article-title":"Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep","volume":"15","author":"David","year":"2008","journal-title":"Gene Ther"},{"issue":"9","key":"10.1016\/j.bpobgyn.2018.02.007_bib93","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/gt.2011.158","article-title":"Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A165 in the uterine arteries of pregnant sheep","volume":"19","author":"Mehta","year":"2012","journal-title":"Gene Ther"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib94","first-page":"A128","article-title":"Prenatal Ad.VEGF gene therapy \u2013 a promising new treatment for fetal growth restriction","volume":"22","author":"Carr","year":"2011","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.bpobgyn.2018.02.007_bib95","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/uog.15880","article-title":"Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction","volume":"47","author":"Sheppard","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib96","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12884-017-1226-7","article-title":"EVERREST prospective study: a 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction. BMC Pregnancy Childbirth","volume":"17","author":"Spencer","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib97","series-title":"The role of emergency and elective interventional radiology in postpartum haemorrhage. Good practise point No 6","author":"RCOG","year":"2007"},{"issue":"3","key":"10.1016\/j.bpobgyn.2018.02.007_bib98","first-page":"129","article-title":"The IGF axis and placental function. a mini review","volume":"69","author":"Forbes","year":"2008","journal-title":"Horm Res"},{"issue":"4","key":"10.1016\/j.bpobgyn.2018.02.007_bib99","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/A:1020957809082","article-title":"Insulin-like growth factor (IGF)-I gene deletion","volume":"3","author":"Camacho-H\u00fcbner","year":"2002","journal-title":"Rev Endocr Metab Disord"},{"issue":"9","key":"10.1016\/j.bpobgyn.2018.02.007_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074632","article-title":"Adenoviral-mediated placental gene transfer of IGF-1 corrects placental insufficiency via enhanced placental glucose transport mechanisms","volume":"8","author":"Jones","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bpobgyn.2018.02.007_bib101","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2217\/nnm-2016-0234","article-title":"Could peptide-decorated nanoparticles provide an improved approach for treating pregnancy complications?","volume":"11","author":"Harris","year":"2016","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/j.bpobgyn.2018.02.007_bib102","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600349","article-title":"Tumor-homing peptides as tools for targeted delivery of payloads to the placenta","volume":"2","author":"King","year":"2016","journal-title":"Sci Adv"},{"issue":"15","key":"10.1016\/j.bpobgyn.2018.02.007_bib103","doi-asserted-by":"crossref","DOI":"10.7150\/thno.19678","article-title":"Selective targeting of a novel vasodilator to the uterine vasculature to treat impaired uteroplacental perfusion in pregnancy","volume":"7","author":"Cureton","year":"2017","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bpobgyn.2018.02.007_bib104","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.1038\/s41598-017-06300-1","article-title":"Treating the placenta to prevent adverse effects of gestational hypoxia on fetal brain development","volume":"7","author":"Phillips","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.bpobgyn.2018.02.007_bib105","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.7150\/thno.18845","article-title":"Placental homing peptide-microRNA inhibitor conjugates for targeted enhancement of intrinsic placental growth signaling","volume":"7","author":"Beards","year":"2017","journal-title":"Theranostics"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693418300488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693418300488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T14:53:10Z","timestamp":1570805590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693418300488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":105,"alternative-id":["S1521693418300488"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2018.02.007","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylaxis and treatment of foetal growth restriction","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2018.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}